Table 5.
Measure | Age | ANOVA | |||||||
---|---|---|---|---|---|---|---|---|---|
M | SD | n | Effect | Mean difference | F ratio | p-value | η2 | ||
Experienced PWS-symptom severity | 5.85 | 2.72 | 86 | 6.112 | 0.003** | 0.128 | |||
Group 1 | 4.29 | 2.56 | 24 | Group 2 | −2.17 | 0.004** | |||
Group 2 | 6.47 | 2.38 | 43 | Group 3 | 0.04 | 1.000 | |||
Group 3 | 6.52 | 2.97 | 19 | Group 1 | 2.13 | 0.025* | |||
Total PTSD-symptoms | 13.81 | 13.33 | 96 | 6.542 | 0.002** | 0.123 | |||
Group 1 | 8.31 | 6.67 | 26 | Group 2 | −10.11 | 0.004** | |||
Group 2 | 18.42 | 14.72 | 48 | Group 3 | 8.14 | 0.042* | |||
Group 3 | 10.27 | 13.33 | 22 | Group 1 | 1.97 | 1.000 | |||
Intrusion | 0.64 | 0.82 | 96 | 4.903 | 0.009** | 0.095 | |||
Group 1 | 0.35 | 0.39 | 26 | Group 2 | −0.54 | 0.018* | |||
Group 2 | 0.89 | 0.67 | 48 | Group 3 | 0.46 | 0.081 | |||
Group 3 | 0.44 | 0.70 | 22 | Group 1 | 0.08 | 1.00 | |||
Avoidance | 0.70 | 1.03 | 96 | 4.674 | 0.012* | 0.091 | |||
Group 1 | 0.35 | 0.68 | 26 | Group 2 | −0.66 | 0.022* | |||
Group 2 | 1.01 | 1.22 | 48 | Group 3 | 0.56 | 0.096 | |||
Group 3 | 0.46 | 0.71 | 22 | Group 1 | 0.11 | 1.000 | |||
Negative alterations in cognitions and mood | 0.66 | 0.73 | 96 | 3.762 | 0.027* | 0.075 | |||
Group 1 | 0.40 | 0.42 | 26 | Group 2 | −0.46 | 0.031* | |||
Group 2 | 0.85 | 0.79 | 48 | Group 3 | 0.30 | 0.32 | |||
Group 3 | 0.55 | 0.80 | 22 | Group 1 | 0.16 | 1.000 | |||
Negative alterations in arousal and reactivity | 0.76 | 0.69 | 96 | 6.030 | 0.003** | 0.115 | |||
Group 1 | 0.51 | 0.50 | 26 | Group 2 | −0.48 | 0.010** | |||
Group 2 | 1.00 | 0.73 | 48 | Group 3 | 0.44 | 0.031* | |||
Group 3 | 0.55 | 0.65 | 22 | Group 1 | 0.04 | 1.000 |
Group 1 consists of family members of PWS patients aged 0 to 9 years. Group 2 consists of family members of PWS patients aged 10 to 30 years. Group 3 consists of family members of PWS patients aged 31 years and older. Intrusion, Avoidance, Negative alterations in cognitions and mood, and Negative alterations in arousal and reactivity represent the four respective PTSD symptom clusters B to E on the PCL-5-NL for DSM-5 (20). The mean difference is significant at the 0.05 level. *p < 0.05. **p < 0.01.